One upcoming decision—on a perioperative PD-1 regimen for lung cancer—comes as the FDA considers an overhaul of trial designs in this treatment setting.
Social media is full of questionable advice. But one of the latest skincare hacks some users are sharing online is seriously worrying. Some content ...
Candid’s launch is indicative of how growing interest in cell therapy for autoimmune diseases has expanded to include T cell engagers, too. Song has paid close attention. After selling RayzeBio to ...